Saturday, July 2, 2022

< + > FTC Goes After PBMs, Warns Of Legal Action

Last month, the FTC voted unanimously to examine rising list prices of insulin, but also to probe possible anti-competitive practices by PBMs. Proof of the establishment of anti-competitive practices - such as rebate walls - would likely lead to legal action being taken against PBMs.

at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

< + > Bonus Features – December 7, 2025 –51% of payers use AI to help avoid interop and prior auth penalties, 38% of patients delayed or skipped care this year due to its cost, plus

Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...